| Literature DB >> 29085816 |
Abstract
The understanding of heart rate variability (HRV) has increased parallel with the development of modern physiology. Discovered probably first in 1847 by Ludwig, clinical applications evolved in the second part of the twentieth century. Today HRV is mostly used in cardiology and research settings. In general, HRV can be measured over shorter (e.g., 5-10 min) or longer (12 or 24 h) periods. Since 1996, most measurements and calculations are made according to the standard of the Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. As the first step, the series of times between successive R-peaks in the ECG are in milliseconds. It is crucial, however, to identify and remove extrasystoles and artifacts according to standard protocols. The series of QRS distances between successive heartbeats can be analyzed with simple or more sophisticated algorithms, beginning with standard deviation (SDNN) or by the square root of the mean of the sum of squares of differences between adjacent normal RR (rMSSD). Short-term HRV is frequently analyzed with the help of a non-parametric fast Fourier transformation quantifying the different frequency bands during the measurement period. In the last decades, various non-linear algorithms have been presented, such as different entropy and fractal measures or wavelet analysis. Although most of them have a strong theoretical foundation, their clinical relevance is still debated.Entities:
Keywords: Holter monitoring; complexity theory; frequency domain; heart rate variability; systems science; time domain
Year: 2017 PMID: 29085816 PMCID: PMC5649208 DOI: 10.3389/fpubh.2017.00265
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Measurement period and parameters.
| Measurement period | Possible parameters |
|---|---|
| 6 s to 2 min | SDNN [Dekker et al. ( |
| 5 min | In addition: rMSSD, HF, LF, LF/HF |
| 10 min | In addition: VLF, approximate entropy |
| hours | In addition: fractal measures |
| 24 h | In addition: ULF |
Physiological factors on heart rate variability (HRV).
| Factor | Effect | Reference |
|---|---|---|
| Sex | Most parameters are lower in women | Stein et al. ( |
| Age | Most HRV parameters decrease with age, except ULF | Bigger et al. ( |
| Weight | Anorexia nervosa: frequency domain↓. Increased BMI: total power (TP)↓. Weight loss >10%: HF↑ | Rechlin et al. ( |
| Food intake | Few studies. Eating a meal had no influence. Dietary restriction: HF↑, LF↓ | Ambarish et al. ( |
| Ethnicity | Problematic factor. One study showed lower HRV in Afro Americans compared to Caucasians but did not control social class | Choi et al. ( |
| Circadian effects | SDNN↑ at night in one study. Most parameters decreased at night | Viola et al. ( |
| Sleep | REM sleep: TP, VLF, LF↑, LF ↓. Non-REM sleep: TP, VLF, LF ↓, LF↑. In light sleep, SDNN, LF and LF/HF values are similar to wakefulness. Sleep deprivation: LF↑, conflicting results | Busek et al. ( |
| Regular exercise | SDNN, TP, HF, fractal dimension↑ | Nakamura et al. ( |
Effects of drugs on heart rate variability.
| Drug | Effect | Reference |
|---|---|---|
| Angiotensin II receptor antagonists | Increase of all time and frequency domain parameters | Petretta et al. ( |
| ACE inhibitors | Increased total power (TP), HF, LF, ULF, VLF, and SDNN | Binkley et al. ( |
| Beta blockers | TP, HF, LF, and VLF↑, rMSSD, pNN50, SDNN and HF↑, in another study no effect | Pousset et al. ( |
| Antidepressiva | SDNN and frequency domain parameters decreased or unchanged | Rechlin ( |
| Caffeine | Increase of SDNN, rMSSD, frequency domain parameters, approximate entropy, detrended fluctuation analysis, or no change | Yeragani et al. ( |
| Sedatives (midazolam, propofol, thiopental) | Decreased HF and LF | Galletly et al. ( |
| Metformin | Increased TP, and HF, decrease in LF and LF/HF ratio | Manzella et al. ( |
| Omega-3 fatty acids | Increased SDNN, rMSSD, HF, VLF, or no change | Mozaffarian et al. ( |
| Digoxin | Increased HF, LF, and rMSSD | Krum et al. ( |
Reference values for some heart rate variability values provided by the Task Force and Nunan {(4) #2317} {(2) #1505}.
| Task force | Nunan ( | |
|---|---|---|
| SDNN (ms) | 141 ± 39 | 50 ± 16 |
| rMSSD (ms) | 27 ± 12 | 42 ± 15 |
| LF (ms2) | 1,170 ± 416 | 519 ± 291 |
| HF (ms2) | 975 ± 203 | 657 ± 777 |
| LF/HF | 1.5 ± 2.0 | 2.8 ± 2.6 |